Established in May 2016, XPiscoric was founded by a group of scientists with extensive experience in drug discovery and development, especially small molecular new drugs (NMEs). The expertises of the XPiscorics scientific team include biological assays, efficacy study in animal models, pharmacokinetics (PK), safety pharmacology and toxicology. The team also possesses successful experiences of IND filing both to FDA and cFDA.